Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test

Summary

To evaluate the efficacy of topical 95% TCA in the treatment of CIN 1 or less after low grade abnormality of screening test

Timeline

Start

2023-11-30

Primary completion

2023-12-01

Completion

2023-12-01

Outcome

Outcome not reported

Stopped: “I have found it is quite difficult to conduct the work without changing some detail in original protocol. So we would like to re-start the study again with some modification.”

Drugs

Indications